As described earlier, our analysis indicated that tyrosine phosphatase PTP4A1 (also called PRL1, phosphatase of regenerating liver 1) may have an oncogenic role in STK11-inactivated NSCLC and that PTP4A1-dependent effects of FTIs in these cancers should be further evaluated. The gene discussed is PTP4A1; the disease is cancer.